For decades, NORD has pursued federal and state policies that will change the lives of Americans impacted by rare diseases for the better. NORD’s work can be viewed below. This page is updated daily to provide timely information. Please contact us if you have questions or need additional information.
NORD and 12 organizations send comment letter to Secretary Yellen and Secretary Becerra on Minnesota’s Section 1332 State Innovation Waiver Extension Application
Published: Jun 30, 2022
Tagged in: Affordable Care Act, Access to Affordable, Adequate Coverage, Medicare, Medicaid, and Private Health Insurance Coverage, Section 1332 Waivers
NORD joins 20 organizations in signing letter to the Minnesota House Health Finance and Policy committee to support the copay-only bill language in HF 3717
Published: Mar 8, 2022
Tagged in: Access to Affordable, Adequate Coverage
NORD and 14 patient organizations submit comments on MN’s mandated health benefit review pertaining to copayments for prescription drugs
Published: Dec 9, 2021
Tagged in: Access to Affordable, Adequate Coverage, Out of Pocket Prescription Drug Costs
NORD joins a one pager with other advocacy organizations on Minnesota SF 365/ HF 633 to help patients manage out-of-pocket costs
Published: Sep 28, 2021
Tagged in: Access to Affordable, Adequate Coverage, Out of Pocket Prescription Drug Costs
NORD joins other patient groups to the Minnesota House and Senate Conference Committee in support of adopting Article 5, Section 7 of the fourth engrossment of HF 2128 to create a copay benefit option for individual and small-group coverage
Published: May 4, 2021
Tagged in: Access to Affordable, Adequate Coverage, Out of Pocket Prescription Drug Costs
